{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:46:10Z","timestamp":1790837170536,"version":"4.1.0"},"reference-count":124,"publisher":"Baishideng Publishing Group Inc.","issue":"32","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2018,8,28]]},"DOI":"10.3748\/wjg.v24.i32.3567","type":"journal-article","created":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T02:27:22Z","timestamp":1535336842000},"page":"3567-3582","source":"Crossref","is-referenced-by-count":44,"title":["Positioning of old and new biologicals and small molecules in the treatment of inflammatory bowel diseases"],"prefix":"10.3748","volume":"24","author":[{"given":"Jason","family":"Reinglas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorant","family":"Gonczi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsuzsanna","family":"Kurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talat","family":"Bessissow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter L","family":"Lakatos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","reference":[{"key":"ref1","unstructured":"Wilks S. Morbid appearances in the intestines of Miss Bankes. Lond Med Gaz 1859; 2: 264-265"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.7.2.181"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.44.515.684"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(62)92080-9"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(77)90831-5"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000543.pub3"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000544.pub4"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004115.pub2"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2011.71"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199406303302601"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198909283211301"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i46.10103"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.02.014"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0904492"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199409293311304"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjw168"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2016.1183648"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32641-7"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2015.233"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08512-4"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2003.11.014"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030815"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.01.048"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2005.08.011"},{"key":"ref25","unstructured":"Cassinotti A, Ardizzone S, Porro GB. Adalimumab for the treatment of Crohn\u2019s disease. Biologics 2008; 2: 763-777"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.11.030"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-146-12-200706190-00159"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2006.106781"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.11.041"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.01.035"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa067594"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20225"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.06.064"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa062897"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2010.01.014"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-302262"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2011.73"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043335"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.03.024"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051586"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051782"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051847"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.109.153973"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1215739"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2014.08.019"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-311079"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1097\/01.MIB.0000194183.92671.b6"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(97)70128-8"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.4161\/mabs.3.6.17815"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1602773"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050516"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61084-8"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.10.032"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2014.242"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.05.048"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.06.010"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000001144"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1215734"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1606910"},{"key":"ref60","unstructured":"Pfizer. Pfizer Announces Favorable Outcome of FDA Advisory Committee Meeting on Xeljanz\u00ae (Tofacitinib) for Moderately to Severely Active Ulcerative Colitis. Accessed March 28, 2018 Available from: URL: https:\/\/www.pfizer.com\/news\/press-release\/press-release-detail\/pfizer_announces_favorable_outcome_of_fda_advisory_committee_meeting_on_xeljanz_tofacitinib_for_moderately_to_severely_active_ulcerative_colitis"},{"key":"ref61","unstructured":"Health Canada. Patented Medicine Prices Review Board. Market Intelligence Report: Biologic Response Modifier Agents. Accessed March 28, 2018 Available from: URL: http:\/\/www.pmprb-cepmb.gc.ca\/CMFiles\/NPDUIS\/PMBRB_16-240_MarketIntelligenceReport_E.pdf"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2016.155"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-203091"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-203090"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jju027.623"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.12997"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-014-3392-z"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjv220"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000995"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjw198"},{"key":"ref71","doi-asserted-by":"crossref","unstructured":"Kim YH, Ye BD, Pesegova M, Alexeeva O, Osipenko M, Lahat A, Dorofeyev A, Salamon A, Fishman S, Levchenko O, Cheon JH, Scribano ML, Mateescu RB, Lee KM, Eun CS, Lee SJ, Lee SY, Kudrin A. Phase III Randomized Controlled Trial to Compare Biosimilar Infliximab (Ct-P13) With Innovator Infliximab in Patients With Active Crohn\u2019s Disease: 1-Year Maintenance and Switching Results. United European Gastroenterol J 2017; 5: Abstract","DOI":"10.1093\/ecco-jcc\/jjx002.098"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30068-5"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-309290"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000709"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13847"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2015.135"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2012.218"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.10.011"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12749"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.7326\/M13-2403"},{"key":"ref81","unstructured":"AbbVie Inc. Study to Evaluate Efficacy and Safety of Two Drug Regimens in Subjects With Moderate to Severe Crohn\u2019s Disease. [accessed 2018 Mar 28]. In: ClinicalTrials.gov [Internet]. Bethesda (MD): U.S. National Library of Medicine. Available from: http:\/\/clinicaltrials.gov\/show\/NCT02065570 ClinicalTrials.gov Identifier: NCT02065570"},{"key":"ref82","unstructured":"AbbVie Inc. Study to Evaluate the Safety and Efficacy of Two Drug Regimens in Subjects With Moderate to Severe Ulcerative Colitis. [accessed 2018 Mar 28]. In: ClinicalTrials.gov [Internet]. Bethesda (MD): U.S. National Library of Medicine. Available from: http:\/\/clinicaltrials.gov\/show\/NCT02065622 ClinicalTrials.gov Identifier: NCT02065622"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.03.003"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2008.159251"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.2147\/CPAA.S138414"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.02.031"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1016\/S1873-9946(12)60012-9"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjw019.028"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.10.052"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjw152"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i43.16014"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2013.04.006"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2014.07.027"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.03.004"},{"key":"ref95","unstructured":"Takeda. Vedolizumab IV 300 mg in the Treatment of Fistulizing Crohn\u2019s Disease (ENTERPRISE). [accessed 2018 Mar 28]. In: ClinicalTrials.gov [Internet]. Bethesda (MD): U.S. National Library of Medicine. Available from: http:\/\/clinicaltrials.gov\/show\/NCT02630966 ClinicalTrials.gov Identifier: NCT02630966"},{"key":"ref96","unstructured":"D\u2019Haens G. An Open Label Phase 4 Study to Evaluate Efficacy of Early Versus Late Use of Vedolizumab in Ulcerative Colitis (LOVE-UC). [accessed 2018 Mar 28]. In: ClinicalTrials.gov [Internet]. Bethesda (MD): U.S. National Library of Medicine. Available from: http:\/\/clinicaltrials.gov\/show\/NCT02646657 ClinicalTrials.gov Identifier: NCT02646657"},{"key":"ref97","unstructured":"Takeda. Triple Combination Therapy in High Risk Crohn\u2019s Disease. [accessed 2018 Mar 28]. In: ClinicalTrials.gov [Internet]. Bethesda (MD): U.S. National Library of Medicine. Available from: http:\/\/clinicaltrials.gov\/show\/NCT02764762 ClinicalTrials.gov Identifier: NCT02764762"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20036"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2007.09.002"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v16.i21.2589"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3462"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2006.105379"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60304-9"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00068-9"},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2007.01265.x"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2012.01.010"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.3109\/00365521.2015.1064991"},{"key":"ref108","unstructured":"Janssen Research & Development, LLC. A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis. [accessed 2018 Mar 28]. In: ClinicalTrials.gov [Internet]. Bethesda (MD): U.S. National Library of Medicine. Available from: http:\/\/clinicaltrials.gov\/show\/NCT01959282 ClinicalTrials.gov Identifier: NCT01959282"},{"key":"ref109","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1407250"},{"key":"ref110","doi-asserted-by":"publisher","DOI":"10.2174\/0929867323666151207111509"},{"key":"ref111","doi-asserted-by":"publisher","DOI":"10.2174\/13894501113149990157"},{"key":"ref112","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjw024"},{"key":"ref113","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.01871.x"},{"key":"ref114","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v11.i8.1187"},{"key":"ref115","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjx009"},{"key":"ref116","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjx117"},{"key":"ref117","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(03)01143-5"},{"key":"ref118","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S1265"},{"key":"ref119","doi-asserted-by":"publisher","DOI":"10.2147\/OARRR.S44550"},{"key":"ref120","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-017-0208-z"},{"key":"ref121","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204231"},{"key":"ref122","doi-asserted-by":"publisher","DOI":"10.3310\/hta15suppl1\/10"},{"key":"ref123","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204248"},{"key":"ref124","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-015-0010-2"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"link":[{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v24\/i32\/3567.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T20:16:43Z","timestamp":1571775403000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v24\/i32\/3567.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,28]]},"references-count":124,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2018,8,28]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.v24.i32.3567","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8,28]]}}}